Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism

Endocrine Practice

Volumn 14, Issue 1, 2008, Pages 69-75

  Cardenas, Monica G ^a   Vigil, Karen J ^a   Talpos, Gary B ^a   Lee, Min W ^a   Peterson, Edward ^a   Rao, D Sudhaker ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFE DIS; ANTIDIABETIC AGENT; GLUCOSE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX RATIO; AGE DISTRIBUTION; COMPARATIVE STUDY; ETHNOLOGY; MIDDLE AGED; SEXUAL DEVELOPMENT; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MICHIGAN; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 40649125320     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.1.69     Document Type: Article

References (36)

1. Procopio M, Borretta G. Derangement of glucose metabolism in hyperparathyroidism. J Endocrinol Invest. 2003;26:1136-1142.
2. Rao DS. Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk? J Endocrinol Invest. 2001;24:131-134.
3. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317-1320.
4. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [erratum in N Engl J Med. 2000;342:144]. N Engl J Med. 1999;341:1249-1255.
5. Silverberg SJ. Editorial: cardiovascular disease in primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:3513-3514.
6. Ljunghall S, Palmér M, Akerström G, Wide L. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest. 1983;13:373-377.
7. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf). 1992;37:147-155.
8. Andersson DE, Röjdmark S, Hed R, Sundblad L. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man. Acta Med Scand. 1982;211:35-43.
9. Hague RV, Cullen DR, Martin TJ. Glucose-induced insulin secretion in patients with parathyroid disorders. Clin Endocrinol (Oxf). 1978;9:283-288.
10. Hellman B. The significance of calcium for glucose stimulation of insulin release. Endocrinology. 1975;97:392-398.
11. Prager R, Kovarik J, Schernthaner G, Woloszczuk W, Willvonseder R. Peripheral insulin resistance in primary hyperparathyroidism. Metabolism. 1983;32:800-805.
12. Prager R, Schernthaner G, Kovarik J, Cichini G, Klaushofer K, Willvonseder R. Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance. Calcif Tissue Int. 1984;36:253-258.
13. Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int. 1995;57:127-132.
14. Yasuda K, Hurukawa Y, Okuyama M, Kikuchi M, Yoshinaga K. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N Engl J Med. 1975;292:501-504.
15. Hruska KA, Blondin J, Bass R, et al. Effect of intact parathyroid hormone on hepatic glucose release in the dog. J Clin Invest. 1979;64:1016-1023.
16. Bevilacqua S, Barrett E, Ferrannini E, et al. Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog. Metabolism. 1981;30:469-475.
17. DeFronzo RA, Lang R. Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med. 1980;303:1259-1263.
18. Valdemarsson S, Lindblom P, Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Intern Med. 1998;244:241-249.
19. Taylor WH. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diabet Med. 1991;8:683-687.
20. Procopio M, Magro G, Cesario F, et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med. 2002;19:958-961.
21. Werner S, Hjern B, Sjöberg HE. Primary hyperparathyroidism. Analysis of findings in a series of 129 patients. Acta Chir Scand. 1974;140:618-625.
22. Palmer M, Adami HO, Bergström R, Jakobsson S, Akerström G, Ljunghall S. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet. 1987;1:59-62.
23. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest. 1998;28:271-276.
24. Michigan Department of Community Health. Michigan Diabetes Fact Pages. http://www.michigan.gov/mdch/0,1607,7-132-2940-2955-2980-13768--,00.html. Updated September 2006. Accessed March 21, 2006.
25. Shaw JH, Croxon M, Holdaway I, Collins JP, Wolfe RR. Glucose, fat, and protein kinetics in patients with primary and secondary hyperparathyroidism. Surgery. 1988;103:526-532.
26. Fadda GZ, Akmal M, Lipson LG, Massry SG. Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol. 1990;258:975-984.
27. Perna AF, Fadda GZ, Zhou XJ, Massry SG. Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol. 1990;259:210-216.
28. Kumar S, Olukoga AO, Gordon C, et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf). 1994;40:47-53.
29. Kim H, Kalkhoff RK, Costrini NV, Cerletty JM, Jacobson M. Plasma insulin disturbances in primary hyperparathyroidism. J Clin Invest. 1971;50:2596-2605.
30. Rao DS, Agarwal G, Talpos GB, et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res. 2002;17(Suppl 2):75-80.
31. Cheung PS, Thompson NW, Brothers TE, Vinik AI. Effect of hyperparathyroidism on the control of diabetes mellitus. Surgery. 1986;100:1039-1047.
32. Taylor WH, Khaleeli AA. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabet Med. 1997;14:386-389.
33. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24:1496.
34. Richards ML, Thompson NW. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery. 1999;126:1160-1166.
35. Bannon MP, van Heerden JA, Palumbo PJ, Ilstrup DM. The relationship between primary hyperparathyroidism and diabetes mellitus. Ann Surg. 1988;207:430-433.
36. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89:5415-5422.